Screener
Alnylam Pharmaceuticals ALNY Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Alnylam Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The source filing: Alnylam Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 8:11 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001178670-26-000062
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cost of collaborations and royalties | 190 | 924 | 3,792 | 1,782 |
| Research and development | 413,134 | 323,621 | 778,000 | 588,743 |
| Selling, general and administrative | 347,922 | 323,314 | 670,473 | 563,263 |
| Total operating costs and expenses | 1,059,507 | 789,888 | 1,958,046 | 1,366,000 |
| Income (loss) from operations | 231,441 | (16,199) | 500,077 | 1,878 |
| Other (expense) income: | ||||
| Interest expense | (82,051) | (61,456) | (151,337) | (119,765) |
| Interest income | 28,143 | 27,486 | 54,741 | 56,159 |
Cover / Front Matter
FAQ
- What is Alnylam Pharmaceuticals's total costs & expenses?
- Alnylam Pharmaceuticals (ALNY) reported total costs & expenses of $1.06B in Q2 2026.
- How has Alnylam Pharmaceuticals's total costs & expenses changed year-over-year?
- Alnylam Pharmaceuticals's total costs & expenses increased by 34.1% year-over-year, from $789.89M to $1.06B.
- What is the long-term trend for Alnylam Pharmaceuticals's total costs & expenses?
- Over 4 years (2021 to 2025), Alnylam Pharmaceuticals's total costs & expenses has grown at a 19.9% compound annual growth rate (CAGR), from $1.55B to $3.21B.
- What does total costs & expenses mean?
- This represents the aggregate of all operating and non-operating costs incurred by the company during a reporting period, including cost of goods sold, research and development, and administrative overhead. It serves as a primary indicator of the company's overall cost discipline and operational scale. Analyzing this metric allows stakeholders to assess the total resource consumption required to sustain the business model.
Ask your AI about Alnylam Pharmaceuticals's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude